Research Projects
Reduction of inflammatory responses against adenoviral vectors to improve safety and efficacy of gene therapy for Dravet syndrome (RIRADS)
Researcher | Principal Investigator
Gene Therapy for Monogenic Encephalopathies Research Group
Research Division
DNA and RNA Medicine Division
Project information
Research project called Reduction of inflammatory responses against adenoviral vectors to improve safety and efficacy of gene therapy for Dravet syndrome (RIRADS) of the Research Group on Gene Therapy for Congenital Encephalopathies of CIMA of the University of Navarra.
PI: Ruben Hernandez-Alcoceba.
Funding agency: Fundacion Síndrome de Dravet (Spain).
Duration: 01/06/2021-01/06/2022.
- Start date: June 1, 2021
- End date: June 1, 2022
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us.